首页 >>2018年09期
新疆维吾尔自治区伊犁地区女性HPV感染状况及基因型别分布
作者:潘贞贞 宋宇宁 张琴 于娇娇 张克南 梁娜 张娜 马欣 朱君玲 者湘漪 夏哈代提 郑威楠 李洪涛 曹冬冬 潘泽民
全文:PDF(806.58 KB)HTML

摘要:

目的  分析新疆维吾尔自治区(新疆)伊犁地区不同民族女性HPV的感染状况及基因型分布情况。方法  采用方便抽样法,选择2015年11月至2017年5月在新疆伊犁地区某综合性医院妇科就诊的54 760名女性为研究对象,采集其宫颈黏液脱落细胞样本,共采集了3 445名;同时收集其民族和年龄等社会信息。纳入标准为有性生活者,宫颈完整者,且民族为汉族、维吾尔族或哈萨克族。采用PCR反向点杂交法,对脱落细胞进行HPV基因分型检测;宫颈癌的诊断由医生根据研究对象的病史、症状、妇科检查结果,以及宫颈细胞学和组织学活检进行确诊。采用χ2检验比较不同民族研究对象HPV阳性率的差异。结果  研究对象的HPV阳性率为25.6%(882例);汉族、维吾尔族和哈萨克族HPV阳性率分别为27.9%(564/2 022)、22.9%(196/857)和21.6%(122/566)(χ2=13.80,P=0.001)。汉族阳性者中感染比例最高的3个亚型依次为HPV16/52/58型,分别占24.8%(140例)、17.7%(100例)和9.8%(55例);维吾尔族依次为HPV16/52/53型,分别占34.2%(67例)、12.8%(25例)、9.2%(18例);哈萨克族依次为HPV16/53/52型,分别占37.7%(46例)、17.2%(21例)、12.3%(15例)。维吾尔族≥61岁研究对象HPV阳性率最高,为41.5%(22例),36~40岁组最低,为15.9%(21例),差异有统计学意义(χ2=35.01,P<0.001)。结论  新疆伊犁地区汉族、维吾尔族和哈萨克族HPV阳性率存在差异,并且感染HPV基因型在不同民族间分布不同。

关键词:子宫颈;癌;基因型;人乳头瘤病毒

Abstract:

Objective  To investigate the infection status and genotype distribution of cervical human papillomavirus (HPV) in women of different ethnic groups and different ages in Yili, Xinjiang Uygur Autonomous Region (Xinjiang).Methods  By using the convenient sampling method, 54 760 women from November 2015 to May 2017 seeking for service in gynecological clinics in a general hospital in Yili, Xinjiang, were selected as the research subjects, and 3 445 samples of cervical mucous exfoliative cells were collected, and the social information of their ethnic and age was collected at the same time. The inclusion criteria were those with sexual life, cervical integrity, and ethnic groups for Han or Uygur or Kazak. PCR-reverse dot blot hybridization was used to detect HPV genotyping in exfoliated cells, and chi-square test was used to compare the difference of HPV positive rate among different ethnic groups. Then, according to ethnicity and age, the differences in positive rates of different ages and ethnic groups were compared in each layer.Results  The positive rate of HPV was 25.6% (882 cases), of which the Han, Uygur and Kazakh were 27.9% (564 cases), 22.9% (196 cases) and 21.6% (122 cases), and the difference was statistically significant (χ2=13.80, P=0.001). The most prevalent high-risk genotypes of Han women were HPV16/52/58, accounting for 24.8% (140 cases), 17.7% (100 cases) and 9.8% (55 cases), respectively. The most prevalent high-risk genotypes of Uygur women were HPV16/52/53, accounting for 34.2% (67 cases), 12.8% (25 cases), 9.2% (18 cases), respectively. The most prevalent high-risk genotypes of Kazak were HPV16/52/53, accounting for 37.7% (46 cases), 17.2% (21 cases), 12.3% (15 cases), respectively. The highest rate of HPV in Uygur patients aged ≥61 years was 41.5% (22 cases), and the lowest in group 36-40 years old, 15.9% (21 cases), the difference between different age groups was statistically significant (χ2=35.01, P<0.001).Conclusion  The positive rate of HPV infection among Han, Uygur and Kazak in Yili Prefecture of Xinjiang was different, and the HPV positive genotype differs among different ethnic groups.

Key words: Cervix uteri;Carcinoma;Genotype;Human papillomavirus

发表日期:2018/9

引用本文:

图/表:

  • 10.3760/cma.j.issn.0253-9624.2018.09.015.T001:表1 不同年龄及不同民族研究对象HPV感染阳性率比较[%(n)];

    10.3760/cma.j.issn.0253-9624.2018.09.015.T001:表1 不同年龄及不同民族研究对象HPV感染阳性率比较[%(n)];

参考文献:

[1]BoschFX, BurchellAN, SchiffmanM, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia[J]. Vaccine, 2008, 26Suppl 10:K1-16. DOI: 10.1016/j.vaccine.2008.05.064.
[2]吴云燕,裘明利.女性高危型人乳头瘤病毒感染分布情况研究[J].中国实用妇科与产科杂志, 2017(1):122-124.
[3]GrovesIJ, ColemanN. Pathogenesis of human papillomavirus-associated mucosal disease[J]. J Pathol, 2015, 235(4):527-538. DOI: 10.1002/path.4496.
[4]ZhuX, LiuH, WuH, et al. Carcinogenic ability quantification of human papilloma virus subtypes in eastern China[J]. J Med Virol, 2015,87(12):2106-2113. DOI: 10.1002/jmv.24280.
[5]TorreLA, BrayF, SiegelRL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015,65(2):87-108. DOI: 10.3322/caac.21262.
[6]ChenW, ZhengR, BaadePD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132. DOI: 10.3322/caac.21338.
[7]古扎丽努尔·阿不力孜,帕提曼·米吉提,李庭芳,等. HPV各亚型在新疆各地区维吾尔族宫颈癌患者中的分布研究[J].新疆医科大学学报,2009,32(5):513-517. DOI: 10.3969/j.issn.1009-5551.2009.05.001.
[8]HuhWK, AultKA, ChelmowD, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance[J]. Obstet Gynecol, 2015,125(2):330-337. DOI: 10.1097/AOG.0000000000000669.
[9]LeinonenMK, NieminenP, L?nnbergS, et al. Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland[J]. BMJ, 2012,345:e7789.
[10]HerfsM, YamamotoY, LauryA, et al. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer[J]. Proc Natl Acad Sci U S A, 2012,109(26):10516-10521. DOI: 10.1073/pnas.1202684109.
[11]阿依佐热姆·穆太力普,萨伊普加玛丽·米吉提,郭桂林,等.新疆维吾尔族、汉族妇女对宫颈癌、HPV及HPV疫苗认知情况的调查分析[J].中国妇幼保健,2015,30(3):434-437. DOI: 10.7620/zgfybj.j.issn.1001-4411.2015.03.37.
[12]Mu?ozN, FranceschiS, BosettiC, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study[J]. Lancet, 2002,359(9312):1093-1101. DOI: 10.1016/S0140-6736(02)08151-5.
[13]常艳红,田林.宫颈癌及癌前病变危险因素的病例对照研究[J].中国卫生统计,2016,33(1):120-122.
[14]LiY, HuangK, JiPL, et al. Cervical Infection of Oncogenic Human Papillomavirus (HPV) Types in Beijing, China[J]. Biomed Environ Sci, 2016,29(10):734-741. DOI: 10.3967/bes2016.098.
[15]ZhangY, WangY, LiuL, et al. Prevalence of human papillomavirus infection and genotyping for population-based cervical screening in developed regions in China[J]. Oncotarget, 2016,7(38):62411-62424. DOI: 10.18632/oncotarget.11498.
[16]MijitF, AblimitT, AbduxkurG, et al. Distribution of human papillomavirus (HPV) genotypes detected by routine pap smear in Uyghur-Muslim women from Karasay Township Hotan (Xinjiang, China)[J]. J Med Virol, 2015,87(11):1960-1965. DOI: 10.1002/jmv.24240.
[17]狄江丽,罗晓敏,吴久玲,等. 2014年中国农村妇女宫颈高危型人乳头瘤病毒感染状况及亚型分布[J].中华预防医学杂志,2017,51(4):325-331. DOI: 10.3760/cma.j.issn.0253-9624.2017.04.009.
[18]ZhangWJ, LiF, WangYH, et al. The case for semi-mandatory HPV vaccination in China[J]. Nat Biotechnol, 2013,31(7):590-591. DOI: 10.1038/nbt.2631.

用户评论 0条

用户名: 密码: 登陆 注册
 
  • 9
  • 3
  •  4 : 页次:0/0页 共0条记录 5条/每页
    关于我们 | 专家风采 | 会员注册 | 继续教育
    地 址:北京东城区东四西大街42号 邮 编:100710
    电话:010-85158365/85158377 传真:010-85158262
    版权所有 中华医学会及中华预防医学杂志编辑部
    京ICP备 07035254 号